While half of all human
tumors possess p53 mutations, inactivation of wild-type p53 can also occur
through a variety of mechanisms that do not involve p53 gene mutation or
deletion. Our laboratory has been interested in tumor cells possessing
wild-type p53 protein and elevated levels of HdmX and/or Hdm2, two critical
negative regulators of p53 function. In this study we utilized RNAi to
knockdown HdmX or Hdm2 in MCF7 human breast cancer cells, which harbor
wild-type p53 and elevated levels of HdmX and Hdm2 then examined gene
expression changes and effects on cell growth. Cell cycle and growth assays
confirmed that the loss of either HdmX or Hdm2 led to a significant growth
inhibition and G1 cell cycle arrest. Although the removal of overexpressed
HdmX/2 appears limited to an anti-proliferative effect in MCF7 cells, the
loss of HdmX and/or Hdm2 enhanced cytotoxicity in these same cells exposed
to DNA damage. Through the use of Affymetrix GeneChips and subsequent
RT-qPCR validations, we uncovered a subset of anti-proliferative p53 target
genes activated upon HdmX/2 knockdown. Interestingly, a second set of
genes, normally transactivated by E2F1 as cells transverse the G1-S phase
boundary, were found repressed in a p21-dependent manner following HdmX/2
knockdown. Taken together, these results provide novel insights into the
reactivation of p53 in cells overexpressing HdmX and Hdm2.
The glycolytic inhibitor 2-deoxy-D-glucose (2-DG) has been shown to enhance the cell death induced by radiation and other DNA damaging agents selectively in cells with high rates of glycolysis, like cancer cells. While energy linked modification of DNA and cellular repair processes have been suggested as possible mechanisms of sensitization, other effects such as global stress response cannot be excluded. In this pilot study, we have investigated the effect of 2-DG and radiation on the transcriptome in an attempt to elucidate how 2-DG impacts gene expression in undamaged verses irradiation (IR) damaged cells using a human malignant glioma cell line, U-87. Exponentially growing U-87 cells were exposed to various combinations of 2-DG and X-rays and total RNA was isolated four hours after exposure. Gene expression changes were elucidated using Affymetrix GeneChips. As expected, U-87 cells treated with 2-DG showed activation of several endoplasmic reticulum stress response genes. Selective RT-PCR and Western blotting confirmed these gene alterations. Given that glucose deprivation leads to p53 activation and 2-DG led to activation of p53 response genes in our present study (e.g., PMAIP1 and GADD45A), we examined the impact of transient p53 knockdown and observed that induction of PMAIP1 and GADD45A appear to be via p53-independent mechanisms. The majority of gene alterations seen with IR-treatment alone were consistent with previous reports. While most gene alterations seen with 2-DG and IR dual treatment were confirmed in the gene profiles seen with individual (2-DG or IR) treatments, several genes appeared differentially regulated between IR and 2-DG (e.g., DUSP8, IL8, GADD45B). Additionally, gene expression patterns suggested alterations in cell cycle regulation, apoptosis, and cytokine signaling pathways. Taken together, this study provides new insights into how the transcriptome of tumor cells are likely to be affected by a combined stress caused by IR and 2-DG.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.